TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 1 | -2 | 7 | -1 | -10 | -28 | -5 |
| P | %wins | 100 | 33 | 100 | 67 | 67 | 0 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/26/15 17:31 | 1/22/15 | VSAR | Versartis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Advent Life Sciences LLP | X0 | H | Affiliat | P.ad | 949 | 17.25 | 3 | 55 | 2 | 2,272 | I | -21 | -11 | -7 | -23 | -23 | -11 | 2 | -3 | 10 | 2 | 1 | -25 | ||
1/26/15 16:59 | 1/22/15 | VSAR | Versartis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Advent Life Sciences LLP | X0 | H | Affiliat | P.d | 949 | 17.25 | 3 | 55 | 2 | 2,272 | I | -21 | -11 | -7 | -23 | -23 | -11 | 2 | -3 | 10 | 2 | 1 | -25 | ||
3/27/14 17:10 | 3/26/14 | VSAR | Versartis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Advent Life Sciences LLP | X0 | T | P.d | 1,260 | 21.00 | 33 | 60 | 3 | 2,217 | I | -2 | 0 | 0 | 0 | -7 | -32 | -33 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |